Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
5.61
-0.14 (-2.43%)
At close: Jun 27, 2025, 4:00 PM
5.52
-0.09 (-1.60%)
After-hours: Jun 27, 2025, 4:09 PM EDT
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $10.75 million as of June 27, 2025. Its market cap has decreased by -62.83% in one year.
Market Cap
10.75M
Enterprise Value
-3.37M
1-Year Change
-62.83%
Ranking
Category
Stock Price
$5.61
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $10.75M, a decrease of -98.44%. That is a compound annual growth rate of -61.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 10.75M | -47.49% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 705.58B |
| Johnson & Johnson | 367.53B |
| AbbVie | 329.36B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 279.54B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 233.19B |
| AstraZeneca | 215.99B |